Commission Directive 2002/69/EC of 26 July 2002 laying down the sampling methods and the methods of analysis for the official control of dioxins and the determination of dioxin-like PCBs in foodstuffs (Text with EEA relevance)
Date: 2002-07-26
Institutions: European Commission
Subjects: food inspection, foodstuff, foodstuffs legislation, public health, toxic substance

6.8.2002

EN

Official Journal of the European Communities

L 209/5

COMMISSION DIRECTIVE 2002/69/EC

of 26 July 2002

laying down the sampling methods and the methods of analysis for the official control of dioxins
and the determination of dioxin-like PCBs in foodstuffs

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Directive 85/591/EEC of 20
December 1985 concerning the introduction of Community
methods of sampling and analysis for the monitoring of food-
stuffs intended for human consumption (1), and in particular
Article 1 thereof,

Whereas:

(1)

(2)

(3)

(4)

Commission Regulation (EC) No 466/2001 (2), as last
amended by Regulation (EC) No 563/2002 (3), and
amended by Council Regulation (EC) No 2375/2001 (4)
establishes maximum limits for dioxins and furans in
certain foodstuffs.

Council Directive 89/397/EEC of 14 June 1989 on the
official control of foodstuffs (5)
lays down the general
principles for the performance of control of foodstuffs.
Council Directive 93/99/EEC of 29 October 1993 on the
subject of additional measures concerning the official
control of foodstuffs (6) introduces a system of quality
standards for
laboratories entrusted by the Member
States with the official control of foodstuffs.

Directive 85/591/EEC has
fixed general criteria for
methods of sampling and analysis. However, in certain
cases it is necessary to lay down more specific criteria
and or requirements with which the method of analysis
should comply in order to ensure that laboratories use
methods of analysis with comparable levels of perfor-
mance.

The provisions for sampling and methods of analysis
have been drawn up on the basis of present knowledge
and they may be adapted to take account of advances in
scientific and technological knowledge.

(5)

The provisions laid down in this Directive relate only to
the sampling and analysis of dioxins and dioxin-like

(1) OJ L 372, 31.12.1985, p. 50.
(2) OJ L 77, 16.3.2001, p. 1.
(3) OJ L 86, 3.4.2002, p. 5.
(4) OJ L 321, 6.12.2001, p. 1.
(5) OJ L 186, 30.6.1989, p. 23.
(6) OJ L 290, 24.11.1993, p. 14.

PCBs for the implementation of Regulation (EC) No 466/
2001 and do not affect the sampling strategy, sampling
levels and frequency as specified in Annexes III and IV to
Council Directive 96/23/EC of 29 April 1996 on
measures to monitor certain substances and residues
in live animals and animal products and
thereof
repealing Directives 85/358/EEC and 86/469/EEC and
Decisions 89/187/EEC and 91/664/EEC (7). They do not
affect the targeting criteria for sampling as laid down in
Commission Decision 98/179/EC of 23 February 1998
laying down detailed rules on official sampling for the
monitoring of certain substances and residues thereof in
live animals and animal products (8).

(6)

(7)

An active approach should be pursued in order to obtain
comprehensive reliable data on the presence of dioxin-
like PCBs in foodstuffs. Requirements should therefore
be laid down as regards the methods of analysis to be
used for the determination of dioxin-like PCBs in food-
stuffs.

A screening method of analysis with proven, widely
acceptable validation and high throughput could be used
to select the samples with significant levels of dioxins.
The levels of dioxins in these samples need to be deter-
mined by a confirmatory method of analysis. It is there-
fore appropriate to establish strict requirements for the
confirmatory methods of analysis and minimum require-
ments for the screening method.

(8)

The measures provided for in this Directive are in accor-
dance with the opinion of the Standing Committee on
the Food chain and Animal Health,

HAS ADOPTED THIS DIRECTIVE:

Article 1

The Member States shall ensure that the sampling for the offi-
cial control of the levels of dioxins and furans and the determi-
nation of the levels of dioxin-like PCBs in foodstuffs is carried
out in accordance with the methods described in Annex I.

(7) OJ L 125, 23.5.1996, p. 10.
(8) OJ L 65, 5.3.1998, p. 31.

L 209/6

EN

Official Journal of the European Communities

6.8.2002

Article 2

Article 4

The Member States shall ensure that sample preparation and
methods of analyses used for the official control of the levels of
the levels of
dioxins and furans and the determination of
criteria
dioxin-like PCBs
described in Annex II.

in foodstuffs comply with the

This Directive shall enter into force on the 20th day following
that of its publication in the Official Journal of the European
Communities.

Article 5

Article 3

This Directive is addressed to the Member States.

Member States shall bring into force the laws, regulations and
administrative provisions necessary to comply with this Direc-
tive by 28 February 2003 at the latest. They shall forthwith
inform the Commission thereof.

When Member States adopt those provisions, they shall contain
a reference to this Directive or be accompanied by such a refer-
ence on the occasion of their official publication. Member
States shall determine how such reference is to be made.

Done at Brussels, 26 July 2002.

For the Commission

David BYRNE

Member of the Commission

6.8.2002

EN

Official Journal of the European Communities

L 209/7

ANNEX I

METHODS OF SAMPLING FOR OFFICIAL CONTROL OF THE LEVELS OF DIOXINS (PCDD/PCDF) AND THE
DETERMINATION OF DIOXIN-LIKE PCBs IN CERTAIN FOODSTUFFS

1.

Purpose and scope

Samples intended for the official control of the levels of dioxins (PCDD/PCDF) content, as well for the determination
of the content of dioxin-like PCBs (1) in foodstuffs shall be taken according to the methods described below.
Aggregate samples thus obtained shall be considered as representative of the lots or sublots from which they are
taken. Compliance with maximum levels laid down in Commission Regulation (EC) No 466/2001 setting maximum
levels for certain contaminants in foodstuffs shall be established on the basis of the levels determined in the
laboratory samples.

2. Definitions

Lot: an identifiable quantity of food delivered at one time and determined by the official to have common
characteristics, such as origin, variety, type of packing, packer, consignor or markings. In the case of fish and fishery
products, also the size of fish shall be comparable.

Sublot: designated part of a large lot in order to apply the sampling method on that designated part. Each sublot
must be physically separated and identifiable.

Incremental sample: a quantity of material taken from a single place in the lot or sublot.

Aggregate sample: the combined total of all the incremental samples taken from the lot or sublot.

Laboratory sample: a representative part/quantity of the aggregate sample intended for the laboratory

(1) Table WHO TEFs for human risk assessment based on the conclusions of the World Health Organisation meeting in Stockholm, Sweden,
15-18 June 1997 (Van den Berg et al., (1998) Toxic Equivalency Factors (TEFs) for PCBs, PCDDs, PCDFs for Humans and for Wildlife.
Environmental Health Perspectives, 106(12), 775).

Congener

TEF value

Congener

TEF value

Dibenzo-p-dioxins (PCDDs)

‘Dioxin-like’ PCBs Non-ortho PCBs + Mono-ortho PCBs

2,3,7,8-TCDD

1,2,3,7,8-PeCDD

1,2,3,4,7,8-HxCDD

1,2,3,6,7,8-HxCDD

1,2,3,7,8,9-HxCDD

1,2,3,4,6,7,8-HpCDD

OCDD

1

1

0,1

0,1

0,1

0,01

0,0001

Non-ortho PCBs

PCB 77

PCB 81

PCB 126

PCB 169

Dibenzofurans (PCDFs)

Mono-ortho PCBs

2,3,7,8-TCDF

1,2,3,7,8-PeCDF

2,3,4,7,8-PeCDF

1,2,3,4,7,8-HxCDF

1,2,3,6,7,8-HxCDF

1,2,3,7,8,9-HxCDF

2,3,4,6,7,8-HxCDF

1,2,3,4,6,7,8-HpCDF

1,2,3,4,7,8,9-HpCDF

OCDF

0,1

0,05

0,5

0,1

0,1

0,1

0,1

0,01

0,01

PCB 105

PCB 114

PCB 118

PCB 123

PCB 156

PCB 157

PCB 167

0,0001

PCB 189

0,0001

0,0001

0,1

0,01

0,0001

0,0005

0,0001

0,0001

0,0005

0,0005

0,00001

0,0001

Abbreviations used: T = tetra; Pe = penta; Hx = hexa; Hp = hepta; O = octa; CDD = chlorodibenzodioxin; CDF = chlorodibenzofuran; CB = chlorobiphenyl.

L 209/8

EN

Official Journal of the European Communities

6.8.2002

3. General provisions

3.1. Personnel

Sampling shall be performed by an authorised qualified person as specified by the Member States.

3.2. Material to be sampled

Each lot, which is to be examined, must be sampled separately.

3.3. Precautions to be taken

In the course of sampling and preparation of laboratory samples precautions must be taken to avoid any changes,
which would affect the content of dioxins and dioxin-like PCBs, adversely affect the analytical determination or make
the aggregate samples unrepresentative.

3.4. Incremental samples

As far as practical incremental samples shall be taken at various places distributed throughout the lot or sublot.
Departure from this procedure must be recorded in the record provided for under 3.8.

3.5. Preparation of the aggregate sample

The aggregate sample is made up by uniting all incremental samples. It shall be at least 1 kg unless not practical, e.g.
when a single package has been sampled.

3.6. Subdivision of aggregate sample in laboratory samples for enforcement, defence and referee purposes

The laboratory samples for enforcement, trade (defence) and referee purposes shall be taken from the homogenised
aggregate sample unless this conflicts with Member States' regulations on sampling. The size of the laboratory
samples for enforcement shall be sufficient to allow at least for duplicate analyses.

3.7. Packaging and transmission of aggregate and laboratory samples

Each aggregate and laboratory sample shall be placed in a clean, inert container offering adequate protection from
contamination, from loss of analytes by adsorption to the internal wall of the container and against damage in
transit. All necessary precautions shall be taken to avoid change of composition of the aggregate and laboratory
samples, which might arise during transportation or storage.

3.8. Sealing and labelling of aggregate and laboratory samples

Each sample taken for official use shall be sealed at the place of sampling and identified following the Member States'
regulations. A record must be kept of each sampling, permitting each lot to be identified unambiguously and giving
the date and place of sampling together with any additional information likely to be of assistance to the analyst.

4.

Sampling plans

The sampling method applied shall ensure that the aggregate sample is representative for the lot that is to be
controlled.

Number of incremental samples

In the case of milk and oils, for which a homogeneous distribution of the contaminants in question can be assumed
within a given lot, it is sufficient to take three incremental samples per lot which forms the aggregate sample.
Reference to the lot number shall be given. For other products, the minimum number of incremental samples to be
taken from the lot shall be as given in Table 1.

The aggregate sample uniting all incremental samples shall be at least 1 kg (see point 3.5). The incremental samples
shall be of similar weight. The weight of an incremental sample should be at least 100 grams. The weight of the
incremental sample is dependent on the size of the particles in the lot. Departure from this procedure must be
recorded in the record provided for under 3.8.
In accordance with the provisions of Commission Decision
97/747/EC of 27 October 1997 fixing the levels and frequencies of sampling provided for by Council Directive
96/23/EC for the monitoring of certain substances and residues thereof in certain animal products (1), the sample size
for hen eggs is at least 12 eggs (for bulk lots as well for lots consisting of individual packages, Tables 1 and 2).

(1) OJ L 303, 6.11.1997, p. 12.

6.8.2002

EN

Official Journal of the European Communities

L 209/9

Minimum number of incremental samples to be taken from the lot

TABLE 1

Weight of lot (in kg)

Minimum number of incremental samples to be taken

< 50

50 to 500

> 500

3

5

10

If the lot consists of individual packages, then the number of packages, which shall be taken to form the aggregate
sample,

is given in Table 2.

Number of packages (incremental samples) which shall be taken to form the aggregate sample if the lot
consists of individual packages

TABLE 2

Number of packages or units in the lot

Number of packages or units to be taken

1 to 25

26 to 100

> 100

1 package or unit

about 5 %, at least 2 packages or units

about 5 %, at maximum 10 packages or units

5. Compliance of the lot or sublot with the specification

The control laboratory shall analyse the laboratory sample for enforcement in duplicate analysis in case the obtained
result of the first analysis is less than 20 % below or above the maximum level, and calculate the mean of the results.
The lot is accepted if the result of the first analysis is more than 20 % below the maximum level or, where duplicate
analysis is necessary, if the mean conforms to the respective maximum level as laid down in Regulation (EC) No
466/2001.

L 209/10

EN

Official Journal of the European Communities

6.8.2002

ANNEX II

SAMPLE PREPARATION AND REQUIREMENTS FOR METHODS OF ANALYSIS USED IN OFFICIAL
CONTROL OF THE LEVELS OF DIOXINS (PCDD/PCDF) AND THE DETERMINATION OF DIOXIN-LIKE PCBs
IN CERTAIN FOODSTUFFS

1. Objective and field of application

These requirements should be applied where foodstuffs are analysed for the official control of the levels of dioxins
(polychlorinated dibenzo-p-dioxins (PCDD) and polychlorinated dibenzofurans (PCDF)) and the determination of
dioxin-like PCBs.

Monitoring for the presence of dioxins in foodstuffs can be performed by a strategy involving a screening method in
order to select those samples with levels of dioxins and dioxin-like PCBs that are less than 30-40 % below or exceed
the level of interest. The concentration of dioxins in those samples with significant levels needs to be determined/
confirmed by a confirmatory method.

Screening methods are methods that are used to detect the presence of dioxins and dioxin-like PCBs at the level of
interest. These methods have a capacity for a high sample throughput and are used to sift large numbers of samples
for potential positives. They are specifically designed to avoid false negatives.

Confirmatory methods are methods that provide full or complementary information enabling the dioxins and
dioxin-like PCBs to be identified and quantified unequivocally at the level of interest.

2.

Background

Because environmental and biological samples (including samples of foodstuffs) in general contain complex mixtures
of different dioxin congeners, the concept of Toxic Equivalency Factors (TEFs) has been developed to facilitate risk
assessment. These TEFs have been established to express concentrations of mixtures of 2,3,7,8-substituted PCDDs
and PCDFs, and more recently, some non-ortho and mono-ortho chlorine substituted PCBs which possesses
dioxin-like activity in toxic equivalents (TEQs) of 2,3,7,8-TCDD (see Annex I, footnote 1).

The concentrations of the individual substances in a given sample are multiplied by their respective TEF and
subsequently summed to give the total concentration of dioxin-like compounds expressed as TEQs.

The concept of ‘upperbound’ requires using the limit of quantification for the contribution of each non-quantified
congener to the TEQ.

The concept of ‘lowerbound’ requires using zero for the contribution of each non-quantified congener to the TEQ.

The concept of ‘mediumbound’ requires using half of the limit of quantification calculating the contribution of each
non-quantified congener to the TEQ.

3. Quality assurance requirements to be complied with for sample preparation

— Measures must be taken to avoid cross-contamination at each stage of the sampling and analysis procedure.

— The samples must be stored and transported in glass, aluminium, polypropylene or polyethylene containers.
Traces of paper dust must be removed from the sample container. Glassware should be rinsed with solvents
previously controlled for the presence of dioxins.

— The sample storage and transportation has to be performed in a way that maintains the integrity of the foodstuff

sample.

— Insofar as relevant, finely grind and mix thoroughly each laboratory sample using a process that has been
demonstrated to achieve complete homogenisation (e.g. ground to pass a 1 mm sieve); samples have to be dried
before grinding if moisture content is too high.

— Perform a blank analysis by carrying out the entire analytical procedure omitting only the sample.

6.8.2002

EN

Official Journal of the European Communities

L 209/11

— Sample weight used for the extraction must be sufficient to fulfil the requirements with respect to sensitivity.

— There are many satisfactory specific sample preparation procedures, which may be used for the products under

consideration. The procedures have to be validated according to internationally accepted guidelines.

4. Requirements for laboratories

— Laboratories shall demonstrate the performance of a method in the range of the level of interest, e.g. 0,5 ×, 1 ×
and 2 × the level of interest with an acceptable coefficient of variation for repeated analysis. For details of
acceptance criteria, see point 5.

— Limit of quantification for a confirmatory method should be in the range of about one fifth of the level of
interest, to make sure that acceptable coefficients of variations are met in the range of the level of interest.

— Regular blank controls and spiking experiments or analysis of control samples (preferably, if available, certified

reference material) should be performed as internal quality control measures.

— Successful participation in interlaboratory studies that assess laboratory proficiency is the best way to prove the
competence in specific analyses. However successful participation in interlaboratory studies for, e.g. soil or
sewage samples, does not necessarily prove the competence also in the field of food or feedingstuff samples,
which present lower contamination levels. Therefore, the continuous participation in interlaboratory studies for
the determination of dioxins and dioxin-like PCBs in the relevant feed/food matrices is mandatory.

— In accordance with the provisions of Directive 93/99/EEC, laboratories should be accredited by a recognised body
operating in accordance with ISO Guide 58 to ensure that they are applying analytical quality assurance.
Laboratories should be accredited following the ISO/IEC/17025:1999 standard.

5. Requirements to be met by analytical procedure for dioxins and dioxin-like PCBs

Basic requirements for acceptance of analytical procedures:

— High sensitivity and low limits of detection. For PCDDs and PCDFs, detectable quantities have to be in the picogram
TEQ (10-12 g) range because of extreme toxicity of some of these compounds. PCBs are known to occur at higher
levels than the PCDDs and PCDFs. For most PCB congeners sensitivity in the nanogram (10-9 g) range is already
sufficient. However, for the measurement of the more toxic dioxin-like PCB congeners (in particular non-ortho
substituted congeners), the same sensitivity must be reached as for the PCDDs and PCDFs.

— High selectivity (specificity). A distinction is required for PCDDs, PCDFs and dioxin-like PCBs from a multitude of
other, coextracted and possibly interfering compounds present at concentrations up to several orders of
magnitude higher than those of the analytes of interest. For gas chromatography/mass spectrometry (GC/MS)
methods a differentiation among various congeners is necessary, such as between toxic (e.g. the seventeen
2,3,7,8-substituted PCDDs and PCDFs and dioxin-like PCBs) and other congeners. Bioassays should be able to
determine TEQ values selectively as the sum of PCDDs, PCDFs and dioxin-like PCBs.

— High accuracy (trueness and precision). The determination should provide a valid estimate of the true concentration
in a sample. High accuracy (accuracy of the measurement: the closeness of the agreement between the result of a
measurement with the true or assigned value of the measurement) is necessary to avoid the rejection of a sample
analysis result on the basis of poor reliability of the estimate of TEQ. Accuracy is expressed as trueness (difference
between the mean value measured for an analyte in a certified material and its certified value, expressed as
percentage of
this value) and precision (precision is usually calculated as a standard deviation including
repeatability and reproducibility, and indicates the closeness of agreement between the results obtained by
applying the experimental procedure several times under prescribed conditions).

Screening methods can comprise bioassays and GC/MS methods; confirmatory methods are high-resolution gas
chromatography/high resolution mass spectrometry (HRGC/HRMS) methods. Following criteria have to be
complied with on total TEQ value:

False negative rate

< 1 %

Screening methods

Confirmatory methods

Trueness

CV

– 20 % to + 20 %

< 30 %

< 15 %

L 209/12

EN

Official Journal of the European Communities

6.8.2002

6.

Specific requirements for GC/MS methods to be complied with for screening or confirmatory purposes

— Addition of 13C-labelled 2,3,7,8-chlorine substituted internal PCDD/F standards (and of 13C-labelled internal
dioxin-like PCB standards, if dioxin-like PCBs have to be determined) must be carried out at the very beginning or
start of the analytical method e.g. prior to extraction in order to validate the analytical procedure. At least one
congener for each of the tetra to octa-chlorinated homologous groups for PCDD/F (and at least one congener for
each of the homologous groups for dioxin-like PCBs, if dioxin-like PCBs have to be determined) must be added
(alternatively, at least one congener for each mass spectrometric selected ion recording function used for
monitoring PCDD/F and dioxin-like PCBs). There is a clear preference, certainly in case of confirmatory methods,
of using all 17 13C-labelled 2,3,7,8-substituted internal PCDD/F standards and all 12 13C-labelled internal
dioxin-like PCB standard (if dioxin-like PCBs have to be determined).

Relative response factors should also be determined for those congeners for which no 13C-labelled analogue is
added by using appropriate calibration solutions.

— For foodstuffs of plant origin and foodstuffs of animal origin containing less than 10 % fat, the addition of the
internal standards is mandatory prior to extraction. For foodstuffs of animal origin containing more than 10 %
fat, the internal standards can be added either before extraction or after fat extraction. An appropriate validation
of the extraction efficiency should be carried out, depending on the stage at which internal standards are
introduced and on whether results are reported on product or fat basis.

— Prior to GC/MS analysis, 1 or 2 recovery (surrogate) standard(s) must be added.

— Control of recovery is necessary. For confirmatory methods, the recoveries of the individual internal standards
should be in the range of 60 % to 120 %. Lower or higher recoveries for individual congeners, in particular for
some hepta- and octa- chlorinated dibenzodioxins and dibenzofurans, are acceptable on the condition that their
contribution to the TEQ value does not exceed 10 % of the total TEQ value (based on PCDD/F only). For
screening methods, the recoveries should be in the range of 30 % to 140 %.

— Separation of dioxins from interfering chlorinated compounds such as PCBs and chlorinated diphenyl ethers
should be carried out by suitable chromatographic techniques (preferably with a florisil, alumina and/or carbon
column).

— Gaschromatographic separation of isomers should be sufficient (< 25 % peak to peak between 1,2,3,4,7,8-

HxCDF and 1,2,3,6,7,8-HxCDF).

— Determination should be performed according to EPA Method 1613 revision B: Tetra- through octa-chlorinated
dioxins and furans by isotope dilution HRGC/HRMS or another with equivalent performance criteria.

— The difference between upperbound level and lower bound level should not exceed 20 % for foodstuffs with a
dioxin contamination of about 1 pg WHO-TEQ/g fat (based on PCDD/PCDF only). For foodstuffs with a low fat
content, the same requirements for contamination levels of about 1 pg WHO-TEQ/g product have to be applied.
For lower contamination levels, for example 0,50 pg WHO-TEQ/g product, the difference between upperbound
and lowerbound level may be in the range of 25 to 40 %.

7.

Screening methods of analysis

7.1. Introduction

Different analytical approaches can be performed using a screening method: a pure screening approach and a
quantitative approach.

S c r e e n i n g a p p r o a c h

The response of samples is compared to that of a reference sample at the level of interest. Samples with a response
less than the reference are declared negative, those with a higher response are suspected positives. Requirements:

— A blank and a reference sample(s) have to be included in each test series, which is extracted and tested at the
same time under identical conditions. The reference sample must show a clearly elevated response in comparison
to a blank.

— Extra reference samples 0,5 × and 2 × the level of interest should be included to demonstrate the proper

performance of the test in the range of interest for the control of the level of interest.

— When testing other matrices, the suitability of the reference sample(s) has to be demonstrated, preferentially by
including samples shown by HRGC/HRMS to contain a TEQ level around that of the reference sample or else a
blank spiked at this level.

6.8.2002

EN

Official Journal of the European Communities

L 209/13

— Since no internal standards can be used in bioassays, tests on repeatability are very important to obtain
information on the standard deviation within one test series. The coefficient of variation should be below 30 %.

— For bioassays, the target compounds, possible interferences and maximum tolerable blank levels should be

defined.

Q u a n t i t a t i v e a p p r o a c h

The quantitative approach requires standard dilution series, duplicate or triplicate clean up and measuring as well as
blank and recovery controls. The result may be expressed as TEQ, thereby assuming that the compounds responsible
for the signal correspond to the TEQ principle. This can be performed by using TCDD (or a dioxin/furan standard
mixture) to produce a calibration curve to calculate the TEQ level in the extract and thus in the sample. This is
subsequently corrected for the TEQ level calculated for a blank sample (to account for impurities from solvents and
chemicals used), and a recovery (calculated from the TEQ level in a quality control sample around the level of
interest). It is essential to note that part of the apparent recovery loss may be due to matrix effects and/or differences
between the TEF values in the bioassays and the official TEF values set by WHO.

7.2. Requirements for methods of analysis used for screening

— GC/MS methods of analysis and bioassays may be used for screening. For GC/MS methods the requirements as
laid down in point 6 are to be used. For cell based bioassays specific requirements are laid down in point 7.3 and
for kit-based bioassays in point 7.4.

— Information on the number of false-positive and false-negative results of a large set of samples below and above
the maximum level or action level
in comparison to the TEQ content as determined by a
confirmatory method of analysis. Actual false negative rates should be under 1 %. The rate of false positive
samples should be low enough to make the use of a screening tool advantageous.

is necessary,

— Positive results have always to be confirmed by a confirmatory method of analysis (HRGC/HRMS). In addition,
samples from a wide TEQ-range should be confirmed by HRGC/HRMS (approximately 2 % to 10 % of the
negative samples). Information on correspondence between bioassay and HRGC/HRMS results should be made
available.

7.3. Specific requirements for cell-based bioassays

— When performing a bioassay, every test run requires a series of reference concentrations of TCDD or a
dioxin/furan mixture (full dose-response curve with a R2 > 0,95). However, for screening purposes an expanded
low level curve for analysing low level samples could be used.

— A TCDD reference concentration (about 3 × limit of quantification) on a quality control sheet should be used for
the outcome of the bioassay over a constant time period. An alternative could be the relative response of a
reference sample in comparison to the TCDD calibration line since the response of the cells may depend on
many factors.

— Quality control (QC) charts for each type of reference material should be recorded and checked to make sure the

outcome is in accordance with the stated guidelines.

— In particular for quantitative calculations, the induction of the sample dilution used must be within the linear
portion of the response curve. Samples above the linear portion of the response curve must be diluted and
re-tested. Therefore, at least three or more dilutions at one time are recommended to be tested.

— The percent standard deviation should not be above 15 % in a triplicate determination for each sample dilution

and not above 30 % between three independent experiments.

— The limit of detection may be set as 3 × the standard deviation of the solvent blank or of the background
response. Another approach is to apply a response that is above the background (induction factor 5 × the solvent
blank) calculated from the calibration curve of the day. The limit of quantification may be set as 5 × to 6 × the
standard deviation of the solvent blank or of the background response or to apply a response that is above the
background (induction factor 10 × the solvent blank) calculated from the calibration curve of the day.

L 209/14

EN

Official Journal of the European Communities

6.8.2002

7.4. Specific requirements for kit-based bioassays (1)

— Manufacturer's instructions for sample preparation and analyses have to be followed.

— Test kits should not be used after the expiration date.

— Materials or components designed for use with other kits should not be used.

— Test kits should be kept within the specified range of storage temperature and used at the specified operating

temperature.

— The limit of detection for immunoassays is determined as 3 × the standard deviation, based on 10 replicate

analysis of the blank, to be divided by the slope value of the linear regression equation.

— Reference standards should be used for tests at the laboratory to make sure that the responsiveness to the

standard is within an acceptable range.

8. Reporting of the result

Insofar as the used analytical procedure makes it possible, the analytical results should contain the levels of the
individual PCDD/F and PCB congeners and be reported as lowerbound, upperbound and mediumbound in order to
include a maximum of information in the reporting of the results and thereby enabling the interpretation of the
results according to specific requirements.

The report should also include the lipid content of the sample as well the method used for lipid extraction.

The recoveries of the individual internal standards must be made available in case the recoveries are outside the range
mentioned in point 6,

is exceeded and in other cases upon request.

in case the maximum level

(1) No evidence have yet been submitted of commercially available kit-based bioassays having sufficient sensitivity and reliability to be

used for screening for the presence of dioxins at the required levels in samples of foodstuffs and feedingstuffs.